CCTA – At the Heart of CAD Diagnosis

Description

Learner Objective

Upon completion of this activity, you should be able to:

Explain the role of CCTA (Coronary Computed Tomography Angiography) as a first-line diagnostic tool for stable patients with suspected coronary artery disease.

Faculty

Kelley R.H. Branch, MD, FACC

University of Washington

Seattle, WA

Disclosures

Consultant Fees/Honoraria: Bayer Healthcare Pharmaceuticals; Hanmi; Janssen

Research/Research Grants: Bayer; Kestra; Sanofi-Aventis

Planning Committee

Monvadi Barbara Srichai-Parsia, MD, FACC

Georgetown University Hospital

Washington, D.C

Disclosures:

Consultant Fees/Honoraria: Artrya; AstraZeneca Pharmaceuticals; Bioclinica; Update

Carol M. Patrick, DNP

Northwell Health

Commack, NY

Disclosures:

Consultant Fees/Honoraria: PCNA (Preventative Cardiovascular Nurses Association); Pfizer/Bristol Myers Squibb

Grant Acknowledgement
Educational grant support for this activity provided by: Heartflow

Summary

Availability:

On-Demand

Access expires on Oct 08, 2026

Cost:

FREE

Credit Offered:

0.75 CME Credit

0.75 CNE Credit

0.75 AAPA Credit

0.75 ABIM-MOC Point

0.75 IPCE Credit